Results 281 to 290 of about 47,830 (314)
Some of the next articles are maybe not open access.
Enantioselective Synthesis of Imperanene, a Platelet Aggregation Inhibitor
Organic Letters, 2001AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Sandra E. Solomon +2 more
openaire +4 more sources
ChemInform Abstract: SUBSTITUTED 3,4‐PENTADIENYLDIAMINES AS INHIBITORS OF PLATELET AGGREGATION
Chemischer Informationsdienst, 1973AbstractKondensation der Allenaldehyde (III) mit den Diaminen (IV) und nachfolgende Reduktion der Schiffschen‐Basen (V) in situ mit Kaliumborhydrid liefern die Pentadienyldiamine (VI), die auf ihre Wirkung als Hemmstoffe der Blutblättchen‐Aggregation untersucht werden.
Thomas R. Blohm +3 more
openaire +4 more sources
2,3-Diphosphoglycerate: A Physiological Inhibitor of Platelet Aggregation
Science, 19752,3-Diphosphoglycerate (2,3-DPG) may inhibit the platelet release reaction and the irreversible aggregation of human blood platelets induced by adenosine diphosphate, epinephrine, or norepinephrine. The effects of 2,3-DPG on platelet aggregation were more pronounced in cases with low hematocrit (< 30 percent).
Sotirios G. Iatridis +3 more
openaire +3 more sources
PLATELET AGGREGATION INHIBITOR IN GARLIC [PDF]
The Lancet, 1981 Susumu Oshiba +2 more
openaire +2 more sources
Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation
Biochemical and Biophysical Research Communications, 1970Phosphorylase activity in suspension of human platelets was assayed prior to and following addition of thrombin and epinephrine which aggregate platelets prostaglandin E1 and E2 and adenosine cyclic 35 monophosphate which inhibit aggregation or sodium fluoride and isoproterenol which alter adenine nucleotide metabolism.
Sidney M. Wolfe +2 more
openaire +4 more sources
Chapter 7. Platelet Aggregation Inhibitors
1971Publisher Summary This chapter presents an overview of the platelet aggregation inhibitors. The therapeutic approach to thromboembolic disease is based on the inhibition of platelet aggregation. The use of fibrinolytic agents for the dissolution of thrombi and the prophylactic use of anticoagulants for their prevention has been known for some time ...
openaire +2 more sources
New Platelet Aggregation Inhibitors [PDF]
Hämostaseologie, 1997 R. Verhaeghe, J. Vermylen
openaire +1 more source
Naphthylalkyl lactamimides as inhibitors of blood platelet aggregation
Journal of Medicinal Chemistry, 1972Grisar Jm +4 more
openaire +3 more sources
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19
Journal of Medical Virology, 2020Zhi Guo, Xiao Chen, Hua Ren
exaly
Clinical pharmacology of inhibitors of platelet aggregation
Pharmacological Research Communications, 1979openaire +3 more sources